A Study Collecting Health Information to Understand and Prevent Gastric Cancer
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT06370143
- Status
- Recruiting
Conditions
- Dysplasia
- Gastric Adenocarcinoma
- Gastric Atrophy
- Gastric Cancer
- Gastric Intestinal Metaplasia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Questionnaire — BEHAVIORALThe questionnaire on clinical, environmental, lifestyle, and dietary risk factors will be administered
Study Details
The purpose of this study is to create a registry of participants with precursor lesions for gastric cancer, including gastric atrophy, intestinal metaplasia, and dysplasia. Normal controls and individuals with gastric cancer for comparison of baseline characteristics will also be enrolled.
Key Dates
- Start date
- Apr 11, 2024
- Status verified
- Jan 2026
- Primary completion
- Apr 11, 2036
- Completion
- Apr 11, 2036
Study Design
- Enrollment
- 3,200 participants (estimated)
Arms
- Arm: Participants with atrophic gastritis, intestinal metaplasia, and dysplasiaParticipants with presence of atrophic gastritis, intestinal metaplasia, and dysplasia and risk of the progression of these lesions
- Arm: Control GroupHealthy controls
- Arm: Participants with gastric cancerParticipants with gastric cancer
Primary Outcome Measure
Creation of participant registry [ Time Frame: Up to 10 years ]
Central Contacts
- Monika Laszkowska, MD212-639-6857
- Xiang Shu, PhD646-227-3658
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | Monika Laszkowska, MD 212-639-6857 |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Middletown | New Jersey | 07748 | Monika Laszkowska, MD 212-639-6857 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | Monika Laszkowska, MD 212-639-6857 |
| Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) | Commack | New York | 11725 | Monika Laszkowska, PhD 212-639-6857 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | Monika Laszkowska, MD 212-639-6857 |
| Memorial Sloan Kettering Cancer Center (All protocol activites) | New York | New York | 10065 | Monika Laszkowska, MD 212-639-6857 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activites) | Rockville Centre | New York | 11553 | Monika Laszkowska, MD 212-639-6857 |
Find similar trials in Basking Ridge, NJ
By condition
By specialty
By research site
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (All Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering Suffolk-Commack (Limited protocol activity)· Commack, NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All protocol activites)· New York, NY
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)PHASE2 · Recruiting · AstraZeneca · Santa Monica, California
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPHASE1 · Recruiting · I-Mab Biopharma US Limited · Orange, California